Prostate Cancer - Results from #2240

LSD1 Promotes Prostate Cancer Reprogramming by Repressing TP53 Signaling Independently of Its Demethylase Function September 1, 2023

Global research status and hotspots of radiotherapy for prostate cancer: a bibliometric analysis based on Web of Science from 2010-2022. September 1, 2023

The influence of secondary resection using NeuroSAFE-technique on sexual function in unilateral nerve-sparing robot-assisted laparoscopic prostatectomies. September 1, 2023

Influencing Best Practices for Genomic and Germline Testing in Urology. September 1, 2023

Impact of androgen receptor alterations on cell-free DNA genomic profiling on survival outcomes in metastatic castration-resistant prostate cancer. September 1, 2023

Plain language summary: Does the amount of time it takes for prostate-specific antigen to double affect how long men with nonmetastatic castration-resistant prostate cancer live and their healthcare costs? September 1, 2023

Trends in prostate cancer screening in the pre- and peri-COVID-19 Pandemic period. September 1, 2023

Elevated periprostatic venous testosterone correlates with prostate cancer progression after radical prostatectomy. September 1, 2023

A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus. September 1, 2023

Prostate-specific membrane antigen-based imaging for stereotactic irradiation of low-volume progressive prostate cancer: a single-center experience. August 31, 2023

First experiences using transurethral ultrasound ablation (TULSA) as a promising focal approach to treat localized prostate cancer: a monocentric study. August 31, 2023

Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer. August 31, 2023

TripleAiM1: a nationwide registry of de novo metastatic hormone-sensitive prostate cancer with prospective quality-of-life assessment. August 31, 2023

In-office dispensing of oral targeted agents by urology practices in men with advanced prostate cancer. August 31, 2023

Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate. August 30, 2023

Same-day Discharge versus Inpatient Robotic Assisted Radical Prostatectomy: Complications, Time-Driven Activity-Based Costing, and Patient Satisfaction. August 30, 2023

Morphologic perfusion patterns and PI-RADSv2.1 in transition zone prostate cancer. August 30, 2023

Sexual Structure Sparing for Prostate Cancer Radiotherapy: A Systematic Review. August 30, 2023

Preclinical Evaluation of a New Series of Albumin-Binding 177Lu-Labeled PSMA-Based Low-Molecular-Weight Radiotherapeutics. August 30, 2023

Impact of cribriform pattern 4 and intraductal prostatic carcinoma on National Comprehensive Cancer Network (NCCN) and Cancer of Prostate Risk Assessment (CAPRA) patient stratification. August 30, 2023

Page 113 of 1439